Advanced in Hepatocerebral Degeneration

Frederic Gottrand

Lille, FR 
Advanced in Hepatocerebral Degeneration
Lille, FR 
OverviewLocationsClinical Research

Overview

Frederic Gottrand practices in Lille, France. Mr. Gottrand is rated as an Advanced expert by MediFind in the treatment of Hepatocerebral Degeneration. His top areas of expertise are Esophageal Atresia, Gastroesophageal Reflux in Infants, Tracheoesophageal Fistula, Gastrostomy, and Endoscopy.

His clinical research consists of co-authoring 354 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Hepatocerebral Degeneration.

Gender
Male

Locations

Lille, France
Other Locations
Boulogne-billancourt, France
Lyon, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: October 10, 2025
A Multicenter, Open-Label, Single- and Multiple-Dose, Dose-Finding Study, With an Optional Open-Label Extension to Assess the Safety, Tolerability, and Pharmacokinetics of Obeticholic Acid in Pediatric Subjects With Biliary Atresia
A Multicenter, Open-Label, Single- and Multiple-Dose, Dose-Finding Study, With an Optional Open-Label Extension to Assess the Safety, Tolerability, and Pharmacokinetics of Obeticholic Acid in Pediatric Subjects With Biliary Atresia
Enrollment Status: Terminated
Publish Date: March 28, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Open-label, 24-Week Safety, Efficacy, and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
A Randomized, Open-label, 24-Week Safety, Efficacy, and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Device, Other, Drug
Study Phase: Phase 3
POLYGEN DEFI-ALPHA : Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort
POLYGEN DEFI-ALPHA : Genetic Polymorphisms Study in Children With Alpha-1 Antitrypsin Deficiency, Included in the DEFI-ALPHA Cohort
Enrollment Status: Completed
Publish Date: November 07, 2018
Intervention Type: Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

353 Total Publications

Title Not Found
Title Not Found
Journal: Sante publique (Vandoeuvre-les-Nancy, France)
Published: October 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gottrand's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 56 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile